TESSENDERLO GROUP (TESB.BR) Stock Fundamental Analysis
Europe - EBR:TESB - BE0003555639 - Common Stock
25.95 EUR
-0.05 (-0.19%)
Overall TESB gets a fundamental rating of 4 out of 10. We evaluated TESB against 66 industry peers in the Chemicals industry. The financial health of TESB is average, but there are quite some concerns on its profitability. TESB has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
TESB had negative earnings in the past year.
TESB had a positive operating cash flow in the past year.
In the past 5 years TESB has always been profitable.
Each year in the past 5 years TESB had a positive operating cash flow.
1.2 Ratios
TESB's Return On Assets of -0.96% is on the low side compared to the rest of the industry. TESB is outperformed by 62.12% of its industry peers.
TESB has a worse Return On Equity (-1.52%) than 60.61% of its industry peers.
TESB has a Return On Invested Capital (2.47%) which is in line with its industry peers.
TESB had an Average Return On Invested Capital over the past 3 years of 6.25%. This is in line with the industry average of 6.62%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.96% | ||
| ROE | -1.52% | ||
| ROIC | 2.47% |
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
1.3 Margins
TESB's Profit Margin has declined in the last couple of years.
TESB has a Operating Margin (2.61%) which is in line with its industry peers.
In the last couple of years the Operating Margin of TESB has declined.
With a Gross Margin value of 19.33%, TESB is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of TESB has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.61% | ||
| PM (TTM) | N/A | ||
| GM | 19.33% |
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
2. Health
2.1 Basic Checks
TESB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
TESB has less shares outstanding than it did 1 year ago.
The number of shares outstanding for TESB has been increased compared to 5 years ago.
The debt/assets ratio for TESB is higher compared to a year ago.
2.2 Solvency
TESB has an Altman-Z score of 2.07. This is not the best score and indicates that TESB is in the grey zone with still only limited risk for bankruptcy at the moment.
TESB has a Altman-Z score (2.07) which is comparable to the rest of the industry.
TESB has a debt to FCF ratio of 2.34. This is a good value and a sign of high solvency as TESB would need 2.34 years to pay back of all of its debts.
TESB has a Debt to FCF ratio of 2.34. This is amongst the best in the industry. TESB outperforms 95.45% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that TESB is not too dependend on debt financing.
TESB has a better Debt to Equity ratio (0.06) than 89.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 2.34 | ||
| Altman-Z | 2.07 |
ROIC/WACC0.35
WACC7.15%
2.3 Liquidity
A Current Ratio of 1.94 indicates that TESB should not have too much problems paying its short term obligations.
TESB has a Current ratio of 1.94. This is in the better half of the industry: TESB outperforms 60.61% of its industry peers.
TESB has a Quick Ratio of 1.18. This is a normal value and indicates that TESB is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of TESB (1.18) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
TESB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -131.08%.
The earnings per share for TESB have been decreasing by -20.75% on average. This is quite bad
Looking at the last year, TESB shows a small growth in Revenue. The Revenue has grown by 2.05% in the last year.
TESB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.72% yearly.
EPS 1Y (TTM)-131.08%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-116.23%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%7.08%
3.2 Future
Based on estimates for the next years, TESB will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.92% on average per year.
Based on estimates for the next years, TESB will show a small growth in Revenue. The Revenue will grow by 3.83% on average per year.
EPS Next Y3.33%
EPS Next 2Y20.55%
EPS Next 3Y19.92%
EPS Next 5YN/A
Revenue Next Year2.34%
Revenue Next 2Y3.91%
Revenue Next 3Y3.83%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
TESB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
TESB is valuated correctly with a Price/Forward Earnings ratio of 15.56.
TESB's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TESB is cheaper than 68.18% of the companies in the same industry.
TESB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.77, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 15.56 |
4.2 Price Multiples
TESB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. TESB is cheaper than 89.39% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, TESB is valued cheaply inside the industry as 84.85% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.19 | ||
| EV/EBITDA | 5.14 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
TESB's earnings are expected to grow with 19.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.55%
EPS Next 3Y19.92%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.02%, TESB has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.04, TESB has a dividend in line with its industry peers.
TESB's Dividend Yield is comparable with the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.02% |
5.2 History
The dividend of TESB is nicely growing with an annual growth rate of 6.16%!
Dividend Growth(5Y)6.16%
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
TESB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of TESB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-166.05%
EPS Next 2Y20.55%
EPS Next 3Y19.92%
EBR:TESB (9/15/2025, 7:00:00 PM)
25.95
-0.05 (-0.19%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners5.92%
Inst Owner ChangeN/A
Ins Owners67.43%
Ins Owner ChangeN/A
Market Cap1.56B
Analysts74
Price Target27.8 (7.13%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.02% |
Yearly Dividend0.88
Dividend Growth(5Y)6.16%
DP-166.05%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.93%
PT rev (3m)0.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-25.96%
EPS NY rev (3m)-25.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.05%
Revenue NY rev (3m)-2.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 15.56 | ||
| P/S | 0.57 | ||
| P/FCF | 14.19 | ||
| P/OCF | 5.41 | ||
| P/B | 0.88 | ||
| P/tB | 1.01 | ||
| EV/EBITDA | 5.14 |
EPS(TTM)-0.45
EYN/A
EPS(NY)1.67
Fwd EY6.43%
FCF(TTM)1.83
FCFY7.05%
OCF(TTM)4.8
OCFY18.49%
SpS45.64
BVpS29.62
TBVpS25.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.96% | ||
| ROE | -1.52% | ||
| ROCE | 3.29% | ||
| ROIC | 2.47% | ||
| ROICexc | 2.77% | ||
| ROICexgc | 3.14% | ||
| OM | 2.61% | ||
| PM (TTM) | N/A | ||
| GM | 19.33% | ||
| FCFM | 4.01% |
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
ROICexc(3y)6.83%
ROICexc(5y)8.71%
ROICexgc(3y)7.61%
ROICexgc(5y)9.79%
ROCE(3y)8.33%
ROCE(5y)10.06%
ROICexcg growth 3Y-43.17%
ROICexcg growth 5Y-19.86%
ROICexc growth 3Y-44.09%
ROICexc growth 5Y-20.16%
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
F-Score6
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 2.34 | ||
| Debt/EBITDA | 0.38 | ||
| Cap/Depr | 80.05% | ||
| Cap/Sales | 6.5% | ||
| Interest Coverage | 7.18 | ||
| Cash Conversion | 97.86% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 2.07 |
F-Score6
WACC7.15%
ROIC/WACC0.35
Cap/Depr(3y)86.45%
Cap/Depr(5y)81.94%
Cap/Sales(3y)5.77%
Cap/Sales(5y)5.54%
Profit Quality(3y)143.93%
Profit Quality(5y)139.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-131.08%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-116.23%
EPS Next Y3.33%
EPS Next 2Y20.55%
EPS Next 3Y19.92%
EPS Next 5YN/A
Revenue 1Y (TTM)2.05%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%7.08%
Revenue Next Year2.34%
Revenue Next 2Y3.91%
Revenue Next 3Y3.83%
Revenue Next 5YN/A
EBIT growth 1Y10.97%
EBIT growth 3Y-34.22%
EBIT growth 5Y-13.98%
EBIT Next Year266.59%
EBIT Next 3Y56.25%
EBIT Next 5YN/A
FCF growth 1Y88.36%
FCF growth 3Y0.11%
FCF growth 5Y5.75%
OCF growth 1Y37.17%
OCF growth 3Y10.33%
OCF growth 5Y8.69%